Physician
Christopher Greater Area Rural Health Planning Corporation
Christopher Greater Area Rural Health Planning Corporation was paid $16.82M by Medicaid between Jan 2018 and Dec 2024, across 130 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 99% of everything it billed.
33Billing provider infoCHRISTOPHER GREATER AREA RURAL HEALTH PLANNING CORPORATION
CHRISTOPHER, IL 62822
CHRISTOPHER, IL 62822
33aNPI1639159213assigned 01/19/2006
33bProvider typeInternal Medicine Physician
28Total paid$16.82M
24GClaims387,950
24DCodes billed130
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in Illinois
Rank by total paid#1 of 3,722
Median peer was paid$26K
This provider vs. median653×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 49,327 | $2.00M | |
| 2019 | 46,819 | $1.26M | |
| 2020 | 38,018 | $1.56M | |
| 2021 | 98,832 | $4.25M | |
| 2022 | 99,497 | $4.79M | |
| 2023 | 32,643 | $1.69M | |
| 2024incomplete | 22,814 | $1.27M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 99% | 144,332 | 103,090 | $16.70M |
| D0999 | Unspecified diagnostic procedure, by report | <1% | 693 | 539 | $68K |
| 0011A | <1% | 302 | 293 | $12K | |
| 0012A | <1% | 270 | 264 | $11K | |
| 0001A | <1% | 132 | 130 | $6K | |
| 90651 | <1% | 956 | 836 | $5K | |
| 0002A | <1% | 89 | 88 | $4K | |
| 0054A | <1% | 90 | 90 | $4K | |
| 0064A | <1% | 86 | 84 | $3K | |
| 90734 | <1% | 1,153 | 1,037 | $3K | |
| 90670 | <1% | 2,576 | 2,202 | $2K | |
| 90633 | <1% | 1,973 | 1,744 | $1K |
118 more codes
| 90834 | Psychotherapy session, about 45 minutes | <1% | 3,028 | $1K |
| 0134A | <1% | 38 | $1K | |
| 90710 | <1% | 916 | $1K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 3,494 | $671.27 |
| 90715 | <1% | 846 | $629.14 | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 82,379 | $492.25 |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 15,396 | $455.47 |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 28 | $342.94 |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 1,650 | $331.65 |
| 90837 | Psychotherapy session, about an hour | <1% | 879 | $300.18 |
| 90686 | <1% | 2,096 | $203.44 | |
| 90698 | <1% | 736 | $188.72 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,386 | $176.77 |
| 90716 | <1% | 85 | $142.10 | |
| 90696 | <1% | 509 | $123.03 | |
| 90681 | <1% | 213 | $117.45 | |
| 90700 | <1% | 218 | $106.15 | |
| 90680 | <1% | 570 | $82.89 | |
| 90707 | <1% | 14 | $77.32 | |
| 90723 | <1% | 977 | $76.95 | |
| 90677 | <1% | 189 | $59.61 | |
| 90647 | <1% | 858 | $58.86 | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,081 | $41.60 |
| Q3014 | Telehealth originating site facility fee | <1% | 471 | $25.00 |
| 81003 | <1% | 3,115 | $2.18 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 10,501 | $1.40 |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 0% | 147 | $0.00 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 4,811 | $0.00 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 4,009 | $0.00 |
| 81025 | 0% | 3,087 | $0.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 3,362 | $0.00 |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 0% | 2,898 | $0.00 |
| 80061 | Lipid panel | 0% | 2,836 | $0.00 |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 0% | 4,070 | $0.00 |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 0% | 2,280 | $0.00 |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 0% | 3,188 | $0.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 732 | $0.00 |
| 83540 | 0% | 241 | $0.00 | |
| 90791 | Psychiatric diagnostic evaluation | 0% | 229 | $0.00 |
| 99173 | 0% | 4,156 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 1,633 | $0.00 |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 0% | 211 | $0.00 |
| 3077F | 0% | 187 | $0.00 | |
| 99204 | Doctor's office visit, new patient (more involved) | 0% | 68 | $0.00 |
| 3078F | 0% | 673 | $0.00 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 0% | 368 | $0.00 |
| 99382 | 0% | 59 | $0.00 | |
| 80321 | 0% | 280 | $0.00 | |
| 83655 | 0% | 524 | $0.00 | |
| 87512 | 0% | 30 | $0.00 | |
| 85014 | 0% | 13 | $0.00 | |
| 82570 | 0% | 83 | $0.00 | |
| 86038 | 0% | 16 | $0.00 | |
| 87481 | 0% | 15 | $0.00 | |
| 80348 | 0% | 28 | $0.00 | |
| D1120 | Dental cleaning, child | 0% | 31 | $0.00 |
| 99201 | 0% | 384 | $0.00 | |
| D0330 | Panoramic radiographic image | 0% | 28 | $0.00 |
| 90648 | 0% | 44 | $0.00 | |
| D0220 | Intraoral - periapical first radiographic image | 0% | 20 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 16 | $0.00 |
| 87799 | 0% | 30 | $0.00 | |
| 87186 | 0% | 12 | $0.00 | |
| 80346 | 0% | 37 | $0.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 16 | $0.00 |
| 80053 | Comprehensive metabolic panel | 0% | 6,098 | $0.00 |
| 87081 | 0% | 164 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 946 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 7,128 | $0.00 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 6,573 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 2,389 | $0.00 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 0% | 1,521 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 3,492 | $0.00 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 25 | $0.00 |
| 81001 | 0% | 525 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 3,139 | $0.00 |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 850 | $0.00 |
| 83550 | 0% | 221 | $0.00 | |
| 82607 | 0% | 399 | $0.00 | |
| 84436 | 0% | 291 | $0.00 | |
| 3074F | 0% | 675 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 8,592 | $0.00 |
| 90474 | 0% | 688 | $0.00 | |
| D0150 | Comprehensive oral evaluation - new or established patient | 0% | 161 | $0.00 |
| 82728 | 0% | 244 | $0.00 | |
| 82043 | 0% | 86 | $0.00 | |
| 87428 | 0% | 7,159 | $0.00 | |
| 82746 | 0% | 367 | $0.00 | |
| 99381 | 0% | 327 | $0.00 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 0% | 187 | $0.00 |
| 87070 | 0% | 362 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 703 | $0.00 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 5,510 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 329 | $0.00 |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 0% | 128 | $0.00 |
| 83735 | 0% | 421 | $0.00 | |
| 87807 | 0% | 818 | $0.00 | |
| 87430 | 0% | 607 | $0.00 | |
| 90744 | 0% | 39 | $0.00 | |
| 99383 | 0% | 148 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 83 | $0.00 |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 0% | 112 | $0.00 |
| 86592 | 0% | 44 | $0.00 | |
| 96127 | 0% | 153 | $0.00 | |
| 84479 | 0% | 268 | $0.00 | |
| 93000 | 0% | 69 | $0.00 | |
| 99384 | 0% | 57 | $0.00 | |
| 36416 | 0% | 53 | $0.00 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 57 | $0.00 |
| 3080F | 0% | 185 | $0.00 | |
| 86580 | 0% | 26 | $0.00 | |
| 87088 | 0% | 96 | $0.00 | |
| D1206 | Topical application of fluoride varnish | 0% | 50 | $0.00 |
| 84153 | 0% | 29 | $0.00 | |
| 85018 | 0% | 14 | $0.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 68 | $0.00 |
| 80349 | 0% | 70 | $0.00 | |
| D0140 | Limited oral evaluation - problem focused | 0% | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMITROKA, KIM (CEO PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Christopher Greater Area Rural Health Planning Corporation | Mt Vernon, IL | $9.52M |
| Christopher Greater Area Rural Health Planning Corporation | Johnston City, IL | $4.42M |
| Christopher Greater Area Rural Health Planning Corporation | Eldorado, IL | $4.25M |
| Christopher Greater Area Rural Health Planning Corporation | Du Quoin, IL | $3.80M |
| Christopher Greater Area Rural Health Planning Corp | Flora, IL | $1.94M |
| Christopher Greater Area Rural Health Planning Corporation | Christopher, IL | $1.80M |
| Christopher Greater Area Rural Health Planning Corporation | Sesser, IL | $544K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.